References
1. Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for
community-acquired pneumonia in adults in Europe: A literature review.Thorax 2013; 68 :1057–1065.
2. Violi F, Cangemi R, Calvieri C. Pneumonia, thrombosis and vascular
disease. J Thromb Haemost 2014;12 :1391-400.
3. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute
pneumonia and the cardiovascular system. Lancet2013;381 :496-505.
4. Violi F, Cangemi R, Falcone M, Taliani G, Pieralli F, Vannucchi V,
Nozzoli C, Venditti M, Chirinos JA, Corrales-Medina VF; SIXTUS
(Thrombosis-Related Extrapulmonary Outcomes in Pneumonia) Study Group.
Cardiovascular Complications and Short Term Mortality Risk in
Community-Acquired Pneumonia. Clin Infect Dis.
2017;64 :1486-1493.
5. Cangemi R, Casciaro M, Rossi E, Calvieri C, Bucci T, Calabrese CM,
Taliani G, Falcone M, Palange P, Bertazzoni G, Farcomeni A, Grieco S,
Pignatelli P, Violi F, Albanese F, Biliotti E, Carnevale R, Catasca E,
Celestini A, Esvan R, Fazi L, Marinelli P, Mordenti M, Napoleone L,
Palumbo M, Pastori D, Perri L, Proietti M, Marco RC, Russo A, et al.
Platelet activation is associated with myocardial infarction in patients
with pneumonia. J Am Coll Cardiol 2014;64 :1917–1925.
6. Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M.
Corticosteroids for pneumonia. Cochrane Database Syst. Rev.2017;12 :CD007720.
7. Jiang S, Liu T, Hu Y, Li R, Di X, Jin X, Wang Y, Wang K. Efficacy and
safety of glucocorticoids in the treatment of severe community-acquired
pneumonia: A meta-analysis. Medicine (Baltimore)2019;98 :e16239.
8. Feldman C, Anderson R. Corticosteroids in the adjunctive therapy of
community-acquired pneumonia: An appraisal of recent meta-analyses of
clinical tria. J Thorac Dis 2016;8 :E162-171.
9. Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC. Efficacy and
safety of corticosteroids for community-Acquired pneumonia: A systematic
review and meta-Analysis. Chest ; 2016;149 :209–219.
10. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K,
Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML,
Musher DM, Restrepo MI, Whitney CG. Diagnosis and treatment of adults
with community-acquired pneumonia. Am J Respir Crit Care Med2019;200 :E45–E67.
11. Cangemi R, Falcone M, Taliani G, Calvieri C, Tiseo G, Romiti GF,
Bertazzoni G, Farcomeni A, Violi F, Battaglia S, Biliotti E, Calabrese
CM, Celestini A, Casciaro M, Angelis M De, Diego I Di, Marzio P De,
Esvan R, Ferraro G, Sulekova LF, Franchi C, Giordo L, Khoury F, Morelli
S, Catassi GN, Palange P, Pastori D, Prosperi A, Raparelli V,
Capparuccia MR, et al. Corticosteroid use and incident myocardial
infarction in adults hospitalized for community-acquired pneumonia.Ann Am Thorac Soc 2019;16 :91–98.
12. Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S,
Werkhoven CH Van, Deursen AMM Van, Sanders EAM, Verheij TJM, Patton M,
McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW,
Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman
B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE.
Polysaccharide conjugate vaccine against pneumococcal pneumonia in
adults. N Engl J Med 2015;372 :1114–1125.
13. Falcone M, Venditti M, Shindo Y, Kollef MH. Healthcare-associated
pneumonia: Diagnostic criteria and distinction from community-acquired
pneumonia. Int J Infect Dis 2011;15 .
14. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean
NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG.
Infectious Diseases Society of America/American Thoracic Society
Consensus Guidelines on the Management of Community-Acquired Pneumonia
in Adults. Clin Infect Dis 2007;44 :S27–S72.
15. Aujesky D, Fine MJ. The Pneumonia Severity Index: A Decade after the
Initial Derivation and Validation. Clin Infect Dis2008;47 :S133–S139.
16. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL,
Cooney M-T, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR,
Løchen M-L, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J,
Richter DJ, Sattar N, Smulders Y, Tiberi M, Worp HB van der, Dis I van,
Verschuren WMM, Binno S, ESC Scientific Document Group. 2016 European
Guidelines on cardiovascular disease prevention in clinical practice.Eur Heart J 2016;37 :2315–2381.
17. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD,
Katus HA, Apple FS, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod
H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D,
Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP,
Menasché P, Ravkilde J, Ohman EM, et al. Third universal definition of
myocardial infarction. Circulation 2012;126 :2020–2035.
18. Cangemi R, Carnevale R, Nocella C, Calvieri C, Cammisotto V, Novo M,
Castellani V, D’Amico A, Zerbinati C, Stefanini L, Violi F, SIXTUS Study
Group. Glucocorticoids impair platelet thromboxane biosynthesis in
community-acquired pneumonia. Pharmacol Res2018;131 :66–74.
19. Carnevale R, Silvestri R, Loffredo L, Novo M, Cammisotto V,
Castellani V, Bartimoccia S, Nocella C, Violi F. Oleuropein, a component
of extra virgin olive oil, lowers postprandial glycaemia in healthy
subjects. Br J Clin Pharmacol 2018;84 :1566–1574.
20. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger
S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T,
Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of
myocardial infarction with sensitive cardiac troponin assays. N
Engl J Med Massachussetts Medical Society; 2009;361 :858–867.
21. Chen Q, Powell DW, Rane MJ, Singh S, Butt W, Klein JB, McLeish KR.
Akt Phosphorylates p47 phox and Mediates Respiratory Burst Activity in
Human Neutrophils . J Immunol The American Association of
Immunologists; 2003;170 :5302–5308.
22. Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Berg JM Ten,
Noordzij PG, Garde EMW van de, Bos WJW, Biesma DH, Endeman H, Hardeman
H, Heijligenberg R, Meijvis SCA, Remmelts HH, Velzen-Blad H van, Voorn
GP (Paul. High-sensitivity cardiac troponin T predicts mortality after
hospitalization for community-acquired pneumonia. Respirology2017;22 :1000–1006.
23. Menéndez R, Méndez R, Aldás I, Reyes S, Gonzalez-Jimenez P, España
PP, Almirall J, Alonso R, Suescun M, Martinez-Dolz L, Torres A.
Community-Acquired Pneumonia Patients at Risk for Early and Long-term
Cardiovascular Events Are Identified by Cardiac Biomarkers. Chest2019;156 :1080–1091.
24. Cangemi R, Calvieri C, Bucci T, Carnevale R, Casciaro M, Rossi E,
Calabrese CM, Taliani G, Grieco S, Falcone M, Palange P, Bertazzoni G,
Celestini A, Pignatelli P, Violi F. Is NOX2 Upregulation Implicated in
Myocardial Injury in Patients with Pneumonia? Antioxid Redox
Signal 2014;20 :2949–2954.
25. Zhang Y, Tocchetti CG, Krieg T, Moens AL. Oxidative and nitrosative
stress in the maintenance of myocardial function. Free Radic Biol
Med. 2012;53 :1531-1540.
26. Sirker A, Murdoch CE, Protti A, Sawyer GJ, Santos CXC, Martin D,
Zhang X, Brewer AC, Zhang M, Shah AM. Cell-specific effects of Nox2 on
the acute and chronic response to myocardial infarction. J Mol
Cell Cardiol 2016;98 :11–17.
27. Zhang M, Perino A, Ghigo A, Hirsch E, Shah AM. NADPH oxidases in
heart failure: Poachers or gamekeepers? Antioxid Redox Signal2013;18 :1024-1241.
28. To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, Chan C,
Drummond GR, Sobey CG, Broughton BRS, Starkey MR, Sluis R Van Der, Lewin
SR, Bozinovski S, O’Neill LAJ, Quach T, Porter CJH, Brooks DA, O’Leary
JJ, Selemidis S. Endosomal NOX2 oxidase exacerbates virus pathogenicity
and is a target for antiviral therapy. Nat Commun.2017;8 :69.
. 29. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa
J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí
C. Effect of corticosteroids on treatment failure among hospitalized
patients with severe community-acquired pneumonia and high inflammatory
response: A randomized clinical trial. JAMA2015;313 :677–686.
30. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A,
Jain SS, Burkhoff D, Kumaraiah D, Rabbani LR, Schwartz A, Uriel N.
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease.Circulation 2020;141 :1648-1655.